Cisen Pharmaceutical Co., Ltd. (SHA:603367)

China flag China · Delayed Price · Currency is CNY
15.66
0.00 (0.00%)
Apr 30, 2026, 9:55 AM CST
17.13%
Market Cap 7.09B
Revenue (ttm) 3.37B
Net Income (ttm) 408.45M
Shares Out 452.75M
EPS (ttm) 0.90
PE Ratio 17.39
Forward PE n/a
Dividend 0.32 (2.11%)
Ex-Dividend Date n/a
Volume 987,100
Average Volume 11,345,450
Open 15.60
Previous Close 15.66
Day's Range 15.57 - 15.70
52-Week Range 13.32 - 35.20
Beta 0.33
RSI 43.91
Earnings Date Apr 3, 2026

About Cisen Pharmaceutical

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products. The company’s chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, anesthetic and analgesic drugs, obstetrics and gynecology medication, digestive system medication, respiratory system medication, immune system drugs, and hormonal dru... [Read more]

Sector Healthcare
Founded 1970
Employees 3,114
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603367
Full Company Profile

Financial Performance

In 2025, Cisen Pharmaceutical's revenue was 3.44 billion, a decrease of -13.48% compared to the previous year's 3.98 billion. Earnings were 421.25 million, a decrease of -17.22%.

Financial Statements

News

There is no news available yet.